These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 19272641

  • 1. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, Robson SC.
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [Abstract] [Full Text] [Related]

  • 2. Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age.
    Lash GE, Otun HA, Innes BA, Percival K, Searle RF, Robson SC, Bulmer JN.
    Hum Reprod; 2010 May; 25(5):1137-45. PubMed ID: 20219775
    [Abstract] [Full Text] [Related]

  • 3. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
    Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, Bulmer JN.
    Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
    [Abstract] [Full Text] [Related]

  • 4. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

  • 5. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system.
    Lash GE, Otun HA, Innes BA, Bulmer JN, Searle RF, Robson SC.
    Biol Reprod; 2006 Feb; 74(2):403-9. PubMed ID: 16251495
    [Abstract] [Full Text] [Related]

  • 6. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
    Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B.
    Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826
    [Abstract] [Full Text] [Related]

  • 7. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000 Nov; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 8. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion.
    De Oliveira LG, Lash GE, Murray-Dunning C, Bulmer JN, Innes BA, Searle RF, Sass N, Robson SC.
    Placenta; 2010 Jul; 31(7):595-601. PubMed ID: 20483454
    [Abstract] [Full Text] [Related]

  • 9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 10. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD.
    Placenta; 2001 Sep; 22(2-3):186-99. PubMed ID: 11170823
    [Abstract] [Full Text] [Related]

  • 12. Effect of tumour necrosis factor-α in combination with interferon-γ on first trimester extravillous trophoblast invasion.
    Otun HA, Lash GE, Innes BA, Bulmer JN, Naruse K, Hannon T, Searle RF, Robson SC.
    J Reprod Immunol; 2011 Jan; 88(1):1-11. PubMed ID: 21112094
    [Abstract] [Full Text] [Related]

  • 13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 14. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER, Snegovskikh V, Schatz F, Foyouzi N, Rahman M, Buchwalder L, Lee HJ, Funai EF, Buhimschi CS, Buhimschi IA, Lockwood CJ.
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [Abstract] [Full Text] [Related]

  • 15. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
    Del Rosso A, Cinelli M, Guiducci S, Pignone A, Fibbi G, Margheri F, Gabrielli A, Giacomelli R, Coppini A, Del Rosso M, Matucci Cerinic M.
    Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
    [Abstract] [Full Text] [Related]

  • 16. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

  • 17. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH.
    Anticancer Res; 2001 Aug; 21(3B):1697-704. PubMed ID: 11497249
    [Abstract] [Full Text] [Related]

  • 18. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 19. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.
    Duffy MJ, Duggan C.
    Clin Biochem; 2004 Jul; 37(7):541-8. PubMed ID: 15234235
    [Abstract] [Full Text] [Related]

  • 20. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y, Hayashi Y, Imai Y, Itoh H.
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.